CH BIOTECH SER(08037) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CH BIOTECH SER (08037) expects a loss attributable to Shareholders of approximately 0.18 billion Hong Kong dollars for the year 2024.
CH BIOTECH SER (08037) announced that the group expects for the fiscal year ending December 31, 2024...
Zhitong FinanceMar 3 06:57 ET
Express News | China Biotech Services - Expected Result Due to Reduction in Revenue From Diminished Demand for Covid-19 Nucleric Acid Test, Others
ReutersMar 3 06:50 ET
Express News | China Biotech Services Sees Net Loss Attributable of HK$180 Mln for FY2024
ReutersMar 3 06:49 ET
CH BIOTECH SER: PROFIT WARNING
HKEXMar 3 06:49 ET · Announcements
CH BIOTECH SER (08037): Hubei Weiyou plans to invest up to 50 million yuan in Pengbo (Hainan).
CH BIOTECH SER (08037) released an announcement on February 27, 2025, Pengbo (Hainan), Dy...
Zhitong FinanceFeb 27 10:25 ET
Express News | China Biotech Services - Registered Capital of Pengbo (Hainan) to Increase to RMB166.7 Mln
ReutersFeb 27 09:49 ET

Comments

Moomoo AI

Feb 17, 2024 18:29

Despite China Biotech Services Holdings' drop in share price and earnings, its high P/E ratio suggests investor optimism. However, weak earnings and slower growth could risk further price decline, challenging to justify without significant medium-term improvements.

Some China Biotech Services Holdings Limited (HKG:8037) Shareholders Look For Exit As Shares Take 30% Pounding

1

Moomoo AI

Dec 29, 2023 16:59

Substantial growth is required by the firm to validate its elevated P/E ratio, but the sustainability of its high stock price is dubious amid recent inconsistencies and dwindling profits. Its high P/E ratio and slower growth rate might contribute to a potential share price fall, risking shareholders and prospective investors.

China Biotech Services Holdings Limited's (HKG:8037) Shares Climb 31% But Its Business Is Yet to Catch Up

08037 CH BIOTECH SER

Trade Overview

Capital Trend

News

Comments